Agios Pharmaceuticals, Inc. (AGIO)
27.30
-0.16
(-0.58%)
USD |
NASDAQ |
Dec 12, 16:00
27.30
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Research and Development Expense (Quarterly): 85.42M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Fulcrum Therapeutics, Inc. | 14.00M |
| Moderna, Inc. | 749.00M |
| EyePoint Plc | 47.75M |
| Vanda Pharmaceuticals, Inc. | 22.56M |